In the carefully monitored confines of a clinical facility, patients with schizophrenia took what looked like an ordinary ...

Medically reviewed by Michael MacIntyre, MDSchizophrenia medication falls under two main categories: older, first-generation, or "typical" antipsychotics and newer drugs for schizophrenia known as ...

Synapse-restoring pill set for human trials as novel schizophrenia treatment A once-a-day pill that regenerates lost nerve cell connections is being trialed as a schizophrenia treatment DALL-E ...

Supplements that may improve symptoms of schizophrenia and its treatment include omega-3 fatty acids, B vitamins, vitamin E, zinc, magnesium, and N-acetylcysteine.

In a Phase III clinical trial conducted by MIT spinout Lyndra Therapeutics, the researchers used the once-a-week pill to deliver a widely used medication for managing the symptoms of schizophrenia ...

For the first time in decades, the Food and Drug Administration has approved a new type of drug for schizophrenia. The twice-a-day pill to be marketed by Bristol Myers Squibb will be called ...

A Phase 3 clinical trial of a new once-weekly risperidone pill for schizophrenia shows it delivers comparable therapeutic effects to daily treatment, offering improved convenience and potential ...

In several studies, only 40% to 60% of people with schizophrenia stay on track with their daily meds. Long-acting drugs solve the problem of having to take medicine every day.

For the first time in decades, the Food and Drug Administration has approved a new type of drug for schizophrenia. The twice-a-day pill to be marketed by Bristol Myers Squibb will be called ...

About 3.7 million, or 1.8%, of adults in the U.S. have a lifetime history of schizophrenia, according to research published in 2023. The estimate was two to three times higher than previous estimates.

WEDNESDAY, Nov. 13, 2024 (HealthDay News) -- People are at higher risk of schizophrenia if they indulge in psychedelic drugs, a new study warns.

MIT researchers developed a pill that can be taken once a week instead of daily, gradually releasing medication from within the stomach. In a phase 3 clinical trial, the treatment maintained ...